SoCal EPAP Nasal Therapy Device for Sleep Apnea: Bongo Rx Availability Expanded

Southern California Pulmonary and Sleep Disorders Medical Center announced the expanded availability of Bongo Rx, an FDA-cleared nasal therapy device designed to help treat mild to moderate obstructive sleep apnea.

-- The Southern California Pulmonary and Sleep Disorders Medical Center announced expanded access to Bongo Rx therapy, a reusable nasal device designed to support individuals diagnosed with obstructive sleep apnea who are seeking an alternative to traditional CPAP therapy. The compact device is designed to help support nighttime breathing and improve sleep quality using a simple, non-powered approach.

People interested in learning more about sleep apnea testing and treatment options can explore additional information at https://sleepmd4u.com/bongo-sleep-apnea-therapy-device/

The therapy was recently introduced as part of a broader effort to expand accessible solutions for people living with sleep apnea. According to the American Academy of Sleep Medicine, an estimated 30 million adults in the United States are affected by sleep apnea, yet many cases remain undiagnosed.

Bongo Rx therapy uses soft nasal inserts that create gentle resistance during exhalation, a mechanism known as expiratory positive airway pressure (EPAP). This resistance helps support the airway during sleep without requiring electricity, hoses, or a bedside machine.

Unlike traditional CPAP devices, Bongo Rx is small, lightweight, and designed to fit directly into the nostrils. Because the device is compact and portable, it can be used during travel and may appeal to individuals who prefer a simpler treatment approach.

The therapy is typically prescribed after sleep apnea testing confirms the condition. Once prescribed, patients receive a set of reusable nasal devices designed for nightly use, with different sizes available to ensure a comfortable fit.

Healthcare professionals increasingly recognize the importance of offering multiple treatment approaches for sleep apnea. While CPAP therapy remains a widely used option, alternative devices such as EPAP-based solutions provide additional choices for individuals exploring ways to support their breathing during sleep.

By expanding access to therapies like Bongo Rx, Thousand Oaks-based Southern California Pulmonary and Sleep Disorders Medical Center aims to provide more flexible care pathways for individuals evaluating sleep apnea treatment after diagnosis. These options may help people address sleep disruptions while maintaining comfort and convenience.

Individuals interested in learning more about sleep apnea testing and treatment options can visit https://sleepmd4u.com/

Contact Info:
Name: Ronald A. Popper, MD, FCCP, FAASM, DABSM
Email: Send Email
Organization: Southern California Pulmonary and Sleep Disorders Medical Center
Address: 317 S. Moorpark Road, Thousand Oaks, CA 91361, United States
Website: https://sleepmd4u.com

Source: PressCable

Release ID: 89186583

In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.14
+4.77 (2.32%)
AAPL  251.49
+3.50 (1.41%)
AMD  202.68
+1.35 (0.67%)
BAC  47.52
+0.36 (0.76%)
GOOG  299.02
+0.23 (0.08%)
META  604.06
+10.40 (1.75%)
MSFT  383.00
+1.13 (0.30%)
NVDA  175.64
+2.94 (1.70%)
ORCL  154.34
+4.66 (3.11%)
TSLA  380.85
+12.89 (3.50%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.